<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE paragraph
  PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd">
<paragraph base="F55753804" id="IFRS17_BC348"><paranum>BC348</paranum><prolog><data name="standard_number" value="IFRS 17"/><data name="paranum" value="BC348"/></prolog><body><bodydiv base="IFRS2020-3">             <p id="IFRS17_P6432">The Board used the disclosure requirements in IFRS 4, including the                 disclosure requirements in <xref base="F59411124" href="../ifrs07/IFRS07_TOC.dita#IFRS07_TOC0001/IFRS07_TOC0001_V2" id="IFRS17_X1795"><ph outputclass="standard_ref"><ph outputclass="standard_number">IFRS 7</ph>                         <ph outputclass="standard_title">Financial Instruments:                         Disclosures</ph></ph></xref> that are incorporated in IFRS 4 by                 cross&#x2011;reference, as a basis for the requirements in IFRS 17. This is because                 stakeholders have indicated that such disclosures provide useful information to                 users of financial statements for understanding the amount, timing and uncertainty                 of future cash flows from insurance contracts. The disclosure requirements brought                 forward from IFRS 4 include information about:</p>             <ol base="F55753807" id="IFRS17_L0537" type="lower-alpha"><li><li_value>(a)</li_value>                     <p base="F55753808" id="IFRS17_P6433">significant judgements in applying the                         Standard, including an explanation of methods used to measure contracts                         within the scope of the Standard, the processes for estimating the inputs to                         those methods, and any changes in those methods and processes (see <xref base="F59411125" href="IFRS17_g117-120.dita#IFRS17_g117-120/IFRS17_g117-120_TI" id="IFRS17_X1796">paragraph 117 of IFRS 17</xref>); and</p></li><li><li_value>(b)</li_value>                     <p base="F55753810" id="IFRS17_P6434">the nature and extent of risks that arise                         from insurance contracts, including:</p>                     <ol base="F55753812" id="IFRS17_L0538" type="lower-roman"><li><li_value>(i)</li_value>                             <p base="F55753813" id="IFRS17_P6435">the exposures to insurance risk                                 and each type of financial risk and how they arise, and the entity&#x2019;s                                 objectives, policies and processes for managing the risk and the                                 methods used to measure those risks (see <xref base="F59411126" href="IFRS17_g121-132.dita#IFRS17_g121-132/IFRS17_g121-132_TI" id="IFRS17_X1797">paragraphs 121&#x2013;125 of                             IFRS 17</xref>);</p></li><li><li_value>(ii)</li_value>                             <p base="F55753815" id="IFRS17_P6436">concentrations of risk (see <xref base="F59411127" href="IFRS17_g127-127.dita#IFRS17_g127-127/IFRS17_g127-127_TI" id="IFRS17_X1798">paragraph 127 of IFRS 17</xref>);</p></li><li><li_value>(iii)</li_value>                             <p base="F55753817" id="IFRS17_P6437">sensitivities to insurance risk                                 and each type of market risk (see <xref base="F59411128" href="IFRS17_g128-129.dita#IFRS17_g128-129/IFRS17_g128-129_TI" id="IFRS17_X1799">paragraphs 128&#x2013;129 of IFRS 17</xref>);<xref type="fn" keyref="footnotes/IFRS17_BC348_FN0001"/></p></li><li><li_value>(iv)</li_value>                             <p base="F55753819" id="IFRS17_P6438">information about claims                                 development (see <xref base="F59411129" href="IFRS17_g130-130.dita#IFRS17_g130-130/IFRS17_g130-130_TI" id="IFRS17_X1800">paragraph 130 of IFRS 17</xref>);</p></li><li><li_value>(v)</li_value>                             <p base="F55753821" id="IFRS17_P6439">information about credit risk                                 arising from insurance contracts, including the credit quality of                                 reinsurance contracts held (see <xref base="F59411130" href="IFRS17_g131-131.dita#IFRS17_g131-131/IFRS17_g131-131_TI" id="IFRS17_X1801">paragraph 131 of IFRS 17</xref>); and</p></li><li><li_value>(vi)</li_value>                             <p base="F55753823" id="IFRS17_P6440">information about liquidity risk                                 arising from insurance contracts (see <xref base="F59411131" href="IFRS17_g132-132.dita#IFRS17_g132-132/IFRS17_g132-132_TI" id="IFRS17_X1802">paragraph 132 of IFRS 17</xref>).</p></li></ol></li></ol>         </bodydiv></body></paragraph>